Hhlr Advisors, Ltd. Zai Lab LTD Transaction History

Hhlr Advisors, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$73.3 - $89.48 $29.3 Million - $35.8 Million	-400,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $7.43 Million - $12.6 Million	-152,256 Reduced 27.57%	400,000 $32.9 Million
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $9.61 Million - $15.5 Million	-245,745 Reduced 30.8%	552,256 $28.4 Million
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $24.3 Million - $30 Million	798,001 New	798,001 $25.8 Million

146

53M

103K

439K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.74B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.